IMODIUM
Pronunciation: loe-PER-a-mide


What it isPeripherally restricted mu agonist slowing gut transit; diarrhea.
Why this oneP-glycoprotein keeps it out of the CNS, so it controls diarrhea without euphoria or dependence at normal doses.
What limits itAt the supratherapeutic doses used for abuse it saturates P-gp and causes torsades and death. Avoid in inflammatory or invasive colitis.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Diarrhea (OTC) | Adults & children ≥12 yr | 2 caplets after first loose stool, then 1 after each subsequent loose stool | 4 caplets/24 hr | |
| Diarrhea (OTC) | Children 9–11 yr (60–95 lb) | 1 caplet after first loose stool, then ½ after each subsequent | 3 caplets/24 hr | |
| Diarrhea (OTC) | Children 6–8 yr (48–59 lb) | 1 caplet after first loose stool, then ½ after each subsequent | 2 caplets/24 hr |
Renal Undefined
Hepatic Undefined
Available strengths
Pregnancy Undefined
Lactation Undefined
| Strength | #/mo | generic $/unit | CostPlus | |
|---|---|---|---|---|
| 1 mg | cap | per unit | not offered | |
| 2 mg | cap | per unit | $0.05/ea | offered |
Generic entry1991
NO BOXED WARNINGS
Principal riskTorsades at the supratherapeutic doses used for abuse
Legacy pregnancy categoryC
Defining liabilityTherapeutic CNS effects are minimal, but high-dose misuse can cause fatal sodium/potassium-channel cardiotoxicity.
Open Loperamide in the interactive console ↗